Table:
begin	end	state
1	15	cytoplasmic
16	40	transmembrane
41	44	non-cytoplasmic
45	73	transmembrane
74	110	cytoplasmic
111	134	transmembrane
135	140	non-cytoplasmic
141	163	transmembrane
164	171	cytoplasmic
172	189	transmembrane
190	205	non-cytoplasmic
206	225	transmembrane
226	258	cytoplasmic
259	281	transmembrane
282	320	non-cytoplasmic
321	344	transmembrane
345	355	cytoplasmic
356	380	transmembrane
381	389	non-cytoplasmic
390	408	transmembrane
409	414	cytoplasmic
415	444	transmembrane
445	464	non-cytoplasmic
465	489	transmembrane
490	508	cytoplasmic

Input:
>GFF2715
METLGFLMDGFAVALTPYNLMFALFGAFVGTLIGCLPGLGPANGVAILIPLAFTLGLPPE
TAMILLTAVYAGAMYGGRISSILLNIPGDEPAMMTCLDGYPMAQKGRAADALAVSAIASF
AGGLIGTIGLIMLAPVLAKFALTFGPAEYFALFLLAFATLGGITGKNPVKTVVAATLGIM
ISTVGIDISTGTQRYTFGVLELYEGIDFILAIVGLFAISELLFFVESRMGRGRDKMNVGK
LTLTMKELVMTIPTQLRGGVLGFISGVLPGAGASLGSFISYTLEKQVVGKKGKFGEGDIR
GVVAPEAGNNGASSGALVPMLTLGVPGSGTTAVLLAMLISLNITPGPLMFTQNADIVWGV
IAALLIGNVLLLVLNIPLVGFFVKLLSVPPMYLLPIVTMVAFVGIYSISHSTFDLYFMVA
FGVAGYFLRKLEIPLVPIILGLLLGPEMEKNLGHALVLSDGEWSVLWASPLAMGLWIVAG
LGLILPYLVGPLLRRRMNAAMKESPVSD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server